News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Real-time Estimate Cboe Europe Other stock markets 10:15:19 2024-04-19 am EDT			5-day change	1st Jan Change
867.2 ^DKK	+0.52%		-1.22%	+24.52%

Apr. 18	India's Biocon developing its own version of Wegovy, clinical trial likely next year	RE
Apr. 15	More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18	RE
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	Apr. 15	GL
Novo Nordisk A/S - share repurchase programme	Apr. 15	GL
More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm	Apr. 15	RE
Biophytis: patent application filed in the field of obesity	Apr. 15	CF
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	Apr. 12	DJ
European Equities Close Mixed in Friday Trading; German Inflation Slows, UK GDP Rises	Apr. 12	MT
Weight-Loss Drugs Like Wegovy Don't Cause Suicidal Thoughts, EU Says	Apr. 12	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Apr. 12	MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says	Apr. 12	MT
European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs	Apr. 12	MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says	Apr. 12	MT
European Medicines Agency Finds No Increased Suicide Risk Link to Novo Nordisk's Wegovy, Ozempic	Apr. 12	MT
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target	Apr. 12	MT
EU regulator finds no link between weight-loss drugs and suicidal thoughts	Apr. 12	RE
Gerresheimer shares down on outlook, but key contracts confirmed	Apr. 11	RE
Gerresheimer supplies 'key players' in GLP-1 drugs market, CEO says	Apr. 11	RE
Gerresheimer expects sales boost from burgeoning obesity drugs sector	Apr. 11	RE
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update	Apr. 10	DJ
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk	Apr. 10	MT